Pharmacologic and Regenerative Cell Therapy for Spinal Cord Injury: WFNS Spine Committee Recommendations
Open Access
- 1 December 2020
- journal article
- review article
- Published by The Korean Spinal Neurosurgery Society in Neurospine
- Vol. 17 (4), 785-796
- https://doi.org/10.14245/ns.2040408.204
Abstract
This is a review article examining the pharmacologic and regenerative cell therapy for spinal cord injury. A literature search during last 10 years were conducted using key words. Case reports, experimental (nonhuman) studies, papers other than English language were excluded. Up-to-date information on the pharmacologic and regenerative cell therapy for spinal cord injury was reviewed and statements were produced to reach a consensus in 2 separate consensus meeting of WFNS Spine Committee. The statements were voted and reached a consensus using Delphi method. Pharmacologic and regenerative cell therapy for spinal cord injury have long been an interest of many experimental and clinical researches. Clinical studies with methylpredinisolone have not shown clear cut benefit. Other drugs such as Rho inhibitor, minocycline, riluzole, granulocyte colony-stimulating factor have also been tried without significant benefits. Regenerative cell therapy using different types of stem cells, different inoculation techniques, and scaffolds have undergone many trials highlighting the efficacies of cells and their limitations. This review article summarizes the current knowledge on pharmacologic and regenerative cell therapy for spinal cord injury. Unfortunately, there is a need for further experimental and human trials to recommend effective pharmacologic and regenerative cell therapy.This publication has 79 references indexed in Scilit:
- Transplantation of Autologous Olfactory Ensheathing Cells in Complete Human Spinal Cord InjuryCell Transplantation, 2013
- Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injuryBrain, 2012
- The Mode of Pretransplant Dialysis Does Not Affect Postrenal Transplant Outcomes in African AmericansJournal of Transplantation, 2012
- Pharmacological Approaches To Repair the Injured Spinal CordJournal of Neurotrauma, 2006
- A Global Perspective on Spinal Cord Injury EpidemiologyJournal of Neurotrauma, 2004
- Methylprednisolone and Interleukin-10 Reduce Gray Matter Damage in the Contused Fischer Rat Thoracic Spinal Cord but Do Not Improve Functional OutcomeJournal of Neurotrauma, 2002
- Riluzole and Methylprednisolone Combined Treatment Improves Functional Recovery in Traumatic Spinal Cord InjuryJournal of Neurotrauma, 2000
- A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord InjuryThe New England Journal of Medicine, 1990
- Methylprednisolone in Spinal Cord Injury: The Possible Mechanism of ActionJournal of Neurotrauma, 1990
- Treatment results of spinal cord injuries in the Swiss paraplegic centre of BasleSpinal Cord, 1976